Actinium Pharmaceuticals to present ATNM-400 cancer-model data at EANM 2026
The company announced oral and poster presentations highlighting broad antitumor activity across lung, colorectal and ovarian cancer models.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.